Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.

BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of ...

The increased genetic complexity and similarity to adult cancers’ genetic diversity could also present new therapeutic opportunities.